Target Name: RBM44
NCBI ID: G375316
Review Report on RBM44 Target / Biomarker Content of Review Report on RBM44 Target / Biomarker
RBM44
Other Name(s): RNA binding motif protein 44 | RNA-binding protein 44 | RBM44_HUMAN | RNA-binding motif protein 44

RBM44: Structure, Function and Potential Drug Targets

RNA binding motif (RBM) proteins are a family of non-protein coding RNAs that play a crucial role in gene regulation. These small RNA molecules are known to interact with the RNA-protein complex, where the RNA acts as a scaffold to recruit proteins to specific protein-protein interaction sites. One of the well-known RBM proteins is RBM44, which is a protein that is expressed in various tissues and cell types. In this article, we will discuss the structure, function, and potential drug targets of RBM44.

Structure and Localization

RBM44 is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and pancreas. It is primarily localized to the cytoplasm and can also be found in the endoplasmic reticulum (ER) and the nuclear pore complex (NPC ). RBM44 is a nuclear protein and its localization to the ER and NPC suggests that it may be involved in the regulation of gene expression.

Function

RBM44 is involved in the regulation of various gene expression pathways, including cell growth, apoptosis, and transcriptional regulation. It has been shown to interact with various RNA binding partners, including AP1, AP2, and AP3. These interactions result in the formation of RNA -protein complexes that are involved in the regulation of gene expression.

One of the well-known functions of RBM44 is its role in the regulation of cell apoptosis. Studies have shown that RBM44 has been shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells . RBM44 has been shown to interact with the protein Bcl-2, which is a known inhibitor of apoptosis. By interacting with Bcl-2, RBM44 may help to regulate apoptosis and protect cells from damage.

Another function of RBM44 is its role in the regulation of transcriptional gene expression. Studies have shown that RBM44 can interact with the protein p16, which is a known regulator of gene expression. This interaction may result in the regulation of gene expression and the expression of target genes.

Potential Drug Targets

RBM44 is a potential drug target due to its involvement in the regulation of gene expression. Many drugs that are currently in use target the RNA-protein complex, including small molecules, peptides, and proteins. These drugs work by binding to specific protein-protein interaction sites on the RNA molecule and modulating its function.

One of the potential drug targets for RBM44 is inhibitors of apoptosis. Since RBM44 is involved in the regulation of cell apoptosis, inhibitors of apoptosis may be effective in treating diseases that are characterized by chronic inflammation, such as cancer, heart disease, and neurodegenerative diseases.

Another potential drug target for RBM44 is small molecules that can interact with RBM44 and modulate its function. Many small molecules have been shown to interact with RNA-protein interfaces and have been shown to be effective in modulating gene expression. For example, small molecules such as rapamycin, curcumin, and resveratrol have been shown to be effective in inhibiting the activity of RBM44 and modulating gene expression.

Conclusion

In conclusion, RBM44 is a non-protein coding RNA that plays a crucial role in the regulation of gene expression. It is involved in the regulation of various gene expression pathways, including cell growth, apoptosis, and transcriptional regulation. RBM44 has been shown to interact with various RNA-protein interaction partners, including AP1, AP2, and AP3, and has been shown to be involved in the regulation of cell apoptosis.

Many drugs that are currently in use target the RNA-protein

Protein Name: RNA Binding Motif Protein 44

Functions: Component of intercellular bridges during meiosis. Intercellular bridges are evolutionarily conserved structures that connect differentiating germ cells. Not required for fertility (By similarity)

The "RBM44 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM44 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL | RBPJP2 | RBPMS | RBPMS-AS1 | RBPMS2 | RBSN | RBX1 | RC3H1 | RC3H2 | RCAN1 | RCAN2 | RCAN3 | RCAN3AS | RCBTB1 | RCBTB2 | RCC1 | RCC1L | RCC2 | RCCD1 | RCE1 | RCHY1 | RCL1 | RCN1 | RCN1P2 | RCN2 | RCN3 | RCOR1 | RCOR2 | RCOR3 | RCSD1 | RCVRN | RD3 | RD3L | RDH10 | RDH11 | RDH12 | RDH13 | RDH14 | RDH16 | RDH5 | RDH8 | RDM1 | RDUR | RDX | RDXP2 | Reactive oxygen species (ROS) | REC114 | REC8 | RECK | RECQL | RECQL4 | RECQL5 | REELD1 | REEP1 | REEP2 | REEP3 | REEP4 | REEP5 | REEP6 | REG1A | REG1B | REG1CP | REG3A